Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers

Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers

Increasing clinical evidence supports the use of direct oral anticoagulants (DOACs) as a potential new therapeutic option for patients suffering from cancer-associated thromboembolism. However, the clinical impact of DOACs compared with traditional anticoagulants on the survival of patients with hea...

Full description

Bibliographic Details
Main Authors: Chien-Lin Lee, Wei-Shan Chen, Yinshen Wee, Ching-Shuen Wang, Wei-Chih Chen, Tai-Jan Chiu, Yu-Ming Wang, Ching-Nung Wu, Yao-Hsu Yang, Sheng-Dean Luo, Shao-Chun Wu
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
direct oral anticoagulants
warfarin
survival
head and neck cancer
cancer-associated thromboembolism
Online Access:https://www.mdpi.com/2072-6694/14/3/703

Similar Items

Similar Items